Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
EDSS variability before randomization may limit treatment discovery in primary progressive MS.
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
Partial acute transverse myelitis is a predictor of multiple sclerosis in children.
Natalizumab Continued Past 24 Months Safely in MS
Self-intermittent catheterization in multiple sclerosis.
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Examining multiple sclerosis through the eyes of a child.
Molecular mimicry as a mechanism for food immune reactivities and autoimmunity.
Pain Affects Depression Through Anxiety, Fatigue, and Sleep in Multiple Sclerosis.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »